Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Apr 28;18(4):307-311.
doi: 10.11909/j.issn.1671-5411.2021.04.009.

Late-chronic cardiotoxicity and heart failure caused by ibrutinib: a case report and literature review

Jian Zhu  1 , Su-Yan Bian  1
Affiliations

Late-chronic cardiotoxicity and heart failure caused by ibrutinib: a case report and literature review

Jian Zhu et al. J Geriatr Cardiol. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
The 12-lead electrocardiogram study.
Figure 2
Figure 2
Coronaries and LV morphology visualized by 64-slice multidetector computed tomography.
Figure 3
Figure 3
Coronary angiographic studies.
Figure 4
Figure 4
Cardiac magnetic resonance imaging results.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Rossi D, Spina V, Gaidano G Biology and treatment of Richter syndrome. Blood. 2018;131:2761–2772. doi: 10.1182/blood-2018-01-791376. - DOI - PubMed
    1. Kluk J, Moonim M, Duran A, et al Cutaneous Richter syndrome: a better place to transform? Br J Dermatol. 2015;172:513–521. doi: 10.1111/bjd.13193. - DOI - PubMed
    1. Vitale C, Ferrajoli A Richter syndrome in chronic lymphocytic leukemia. Curr Hematol Malig Rep. 2016;11:43–51. doi: 10.1007/s11899-016-0300-y. - DOI - PubMed
    1. Wang ML, Blum KA, Martin P, et al Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results. Blood. 2015;126:739–745. doi: 10.1182/blood-2015-03-635326. - DOI - PMC - PubMed
    1. Treon SP, Tripsas CK, Meid K, et al Ibrutinib in previously treated Waldenström’s macroglobulinemia. N Engl J Med. 2015;372:1430–1440. doi: 10.1056/NEJMoa1501548. - DOI - PubMed

LinkOut - more resources